Bioventus Inc reports results for the quarter ended in December - Earnings Summary

Bioventus

12/03/2024 13:31

* Bioventus Inc  BVS.OQ  reported quarterly adjusted
earnings of 7
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -6
cents.  The mean expectation of three analysts for the quarter
was for earnings of 2 cents per share. Wall Street expected
results to range from -5 cents to 6 cents per share.
    * Revenue rose 7.6% to $135.42 million from a year ago;
analysts
expected $123.96 million. 
    * Bioventus Inc's reported EPS for the quarter was a loss
of 10
cents​.
    * The company reported a quarterly loss of $6.1 million.
    * Bioventus Inc shares had risen by 0.8% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Bioventus Inc is
$6.50 
This summary was machine generated from LSEG data March 12 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.02           0.07           Beat
 Sep. 30 2023      -0.02          0.05           Beat
 Jun. 30 2023      0.00           0.14           Beat
 Mar. 31 2023      -0.15          -0.26          Missed